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In the periphery, T helper cell differentiation is a key event orchestrating the adaptive immune response yet
recent studies demonstrate considerable plasticity in these cell fate decisions. In this issue of Immunity,
Mukasa et al. (2010) describe the epigenetic basis underlying this plasticity.In eukaryotes, DNA is tightly packaged
around octamers of histone proteins,
which in turn form into larger chromatin
structures. Tightly condensed chromatin
forms a physical barrier to the transcrip-
tional machinery so that only accessible
and ‘‘open’’ areas of the chromatin
possess transcriptional potential. Devel-
opmentally regulated genes in metazoans
require cis-regulatory elements for faithful
transcription (Woolfe and Elgar, 2008).
So, not only must mammalian genes lie
in accessible chromatin, but their regula-
tory elements must also be open if
they are either promoting an active gene
or promoting a gene that might become
active. The precise mechanisms govern-
ing cis-regulation is incompletely under-
stood and a source of much active
research. It is known that a good deal of
chromosomal regulation occurs by post-
translational modifications of histones.
These histone modifications provide>
additional information above the genetic
code, hence ‘‘epigenetic,’’ code. Active
genes and their cis-regulatory elements,
associated with open chromatin as
measured by DNase hypersensitivity, are
correlated with the histone-3 lysine-4 tri-
methyl mark (H3K4me3). Closed and
inaccessible chromatin is associated with
a separate histone mark, H3K27me3
(Wang et al., 2008). It is theorized that
gene loci poised for developmental deci-
sions are marked with both H3K4me3
and H3K27me3 (Mikkelsen et al., 2007).
After antigen stimulation, naive CD4+
T cells undergo clonal expansion and
additional differentiation paths to pro-
duce key effector cytokines enabling the
adaptive immune system to develop
appropriate host responses to distinct
pathogens (Reiner, 2007). These effector
cytokines include IFN-g, produced by T
helper 1 (Th1) cells; interleukin-4 (IL-4),
IL-5, and IL-13, produced by Th2 cells;and IL-17A, IL-17F, and IL-22, produced
by Th17 cells. A key feature of these
differentiation paths is that each effector
lineage expresses its signature cytokine
gene and actively represses expression
of the alternative effector cytokine genes.
Each lineage has its own set of trans-
criptional ‘‘master regulators’’ that direct
these cell fate decisions. In polarized
CD4+ T cell subsets, effector cytokine loci
exhibit stable epigenetic marks, which
reinforce the subset’s cytokine expres-
sion pattern. For example, the Th1 cell
fate decision is reflected by long-range,
repressive H3K27me3 marks across the
Il4 locus and long-range, permissive
H3K4me3 marks across the Ifng locus
(Wei et al., 2009). However, on a cellular
basis, these lineage decisions exhibit
a certain amount of plasticity and Th1,
Th2, or Th17 cells can be ‘‘repolarized’’ if
cultured under conditions that drive alter-
native fate decisions of effector T cells
(Zhou et al., 2009). Notably, after stimula-
tion with IL-12, in vitro, Th17 cells can
switch from a Th17 cell cytokine profile
to a Th1 cell cytokine profile (Lee et al.,
2009; Lexberg et al., 2008). If expression
patterns in CD4 subsets are maintained
by stable epigenetic marks, then how
can an in vitro cultured CD4+ T cell shift
from a Th17 cell subset to a Th1 cell
subset?
Mukasa et al. attempt to answer this
question by examining chromatin acces-
sibility at Ifng and Il17a, Il17f, effector
gene loci in Th1, Th17, and Th17 cells
repolarized to Th1 cells with IL-12
(Th17+IL-12). They quantify DNase hyper-
sensitivity and both H3K4me3 and
H3K27me3 histone marks across the
Ifng and Il17a and Il17f loci. The authors
find that conserved noncoding DNA
sequences (CNSs) within the Ifng locus
have DNase HS in both Th1 and Th17
cells, as well as being marked byImmunityH3K4me3 in both cell types. Conversely,
the Il17a and Il17f locus only has DNase
HS in Th17 cells and is marked with
long-range, repressive H3K27me3 in Th1
cells. Upon repolarization from a Th17
cell to a Th17+IL-12 cell, H3K4me3 and
H3K27me3 histone marks and DNase
hypersensitivity of both the Ifng and Il17a
and Il17f loci fully resemble those
observed in Th1 cells. That is, Th17 cells
keep their option for expression of Ifng
open, literally if referring to chromatin
accessibility (Figure 1), whereas Th1 cells
close off their Il17a and Il17f locus. The
conversion of histone marks and DNase
hypersensitivity from a Th17 to a Th17+
IL-12 cell is T-bet and STAT4 dependent,
whereas being inhibited by the Th17 tran-
scription factor RORgt. Repolarization is
associated with recruitment of T-bet to
the RORgt gene locus and alterations in
histone marks, followed by alterations in
histone marks at the Il17 locus. Thus,
another key element of the study is that
both cytokine gene loci and loci of
transcriptional ‘‘master regulators’’ are
subject to repolarization.
It is becoming increasingly clear that
transcriptional regulation of effector cyto-
kine genes requires regions of genomic
DNA extending far beyond the coding
regions of these genes. Evolutionary
sequence conservation and epigenetic
regulation across these regions support
these notions. Yet, no universal model
exists to mechanistically explain cis-
regulation for all genes. The differences
between the Ifng locus and the Il17a and
Il17f locus described by Mukasea et al.
are striking. The Ifng locus exhibits wide-
spread DNase hypersensitivity sites in
naive, Th1, and Th17 cells, with all DNase
sites other than those at CNS-6 and
CNS-34 present in all cell types analyzed.
In contrast the Il17a and Il17f locus
acquires very few DNase hypersensitivity32, May 28, 2010 ª2010 Elsevier Inc. 581
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Figure 1. Epigenetic Dynamics at the Ifng and Il17 Gene Loci during Th1-Th17 Cell Differentiation
Naive CD4+ T cells do not express effector cytokine genes, such as Ifng and Il17, but must endure specific differentiation paths to acquire the ability to do so.
Mukasa et. al. (2010) show that CD4+ T cells employ markedly different strategies to silence these genes in the naive state and to express these genes upon
differentiation into a Th1 or Th17 cell as revealed by analysis of DNAse hypersensitivity and patterns of histone marks across the Ifng and Il17 gene loci. This
phenotypic plasticity inherent within different effector T cell lineages is achieved by complex patterns of epigenetic modifications, which are unique to each
cell type and each genomic locus. Green disks indicate histone octamers wrapped around by DNA in a closed configuration, densely packed, or an open config-
uration, loosely packed. Green flags represent H3K4me3 ‘‘marks’’ and red stop signs identify H3K27me3 ‘‘marks.’’
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Previewssites, almost all of which exist purely in
Th17 cells. During Th1 or Th17 cell devel-
opment the Ifng locus is not only marked
with H3K4me3 or H3K27me3, respec-
tively, but also with both marks on the
same conserved noncoding sequences.
Dual marks were not observed on the
Il17a and Il17f locus in highly purified
Th17 cells. Both loci have activation-
induced DNase hypersensitivity sites,
Ifng at CNS-6 and Il17a and Il17f at
CNS-5. Given these findings, future work
should determine whether cis-regulatory
elements within the Il17a and Il17f locus
are mechanistically unique from those in
other cytokine loci. If multiple regulatory
elements do exist, what purpose do they
serve and how do they function? Given
the epigenetic plasticity seen in the Il17a
and Il17f locus, compared to the Ifng
locus, which cis-regulatory elements are
required to initiate transcription, to allow
epigenetic plasticity, and/or to lock in
a transcriptional profile?
There are important technical consid-
erations when interpreting the study.
The ex vivo culture system used by Mu-
kasa et al. limits any extrapolation to an
intact immune system. In vivo conditions
could be more flexible, allowing for both582 Immunity 32, May 28, 2010 ª2010 Elsevithe Ifng and Il17a and Il17f loci to be
accessible and transcribed. Or, in vivo
conditions could be more restrictive, in
which case the study may not mirror
events occurring, in vivo, in response to
pathogen exposure. It will be important
to determine how well the models
described here are fully recapitulated in
other placental mammals. Sill, it is
tempting to put the results presented
by Mukasea et al. in context of the
immune system. What is the fitness
benefit to the host by maintaining epige-
netic permissibility at key effector cyto-
kine gene loci early during infection by
a pathogen? These effector cytokines are
very potent inflammatory proteins and
their production does not come without
a benefit or a cost. Their insufficient
production could lead to failure to control
infection while their excessive production
could lead to symptoms of septicemia.
Further, inappropriate differentiation of
these effector T cells in response to, for
example, self-antigen could lead to auto-
immunity. Thus, one possibility is that the
immune system may ‘‘keep its options
open’’ by maintaining plasticity at these
key effector cytokine gene loci early
during an immune response. Further,er Inc.‘‘extra’’ conserved noncoding regions
exist within the Il17a and Il17f locus,
which were not associated with DNase
hypersensitivity in the present study.
What, if any, are the functions of these
CNSs? Additional cells of hematopoietic
origin express IL-17. Are separate
genomic elements required for expres-
sion in Th17 cells versus expression in
other cells, e.g., NKT cells? Lastly,
because reprogramming developmental
decisions is of clinical relevance, how
can the Th17 to Th17+IL-12 cell epige-
netic conversion model be applied to
other developmentally regulated loci?REFERENCES
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Despite the importance of the cytokine receptor flt3 in dendritic cell (DC) homeostasis, little is known about its
regulation during DC development. In this issue of Immunity, Carotta et al. (2010) reveal that the transcription
factor PU.1 controls Flt3 expression in hematopoietic progenitors in a dose-dependent manner.Since their original identification in the
1970s (Steinman and Banchereau,
2007), the ontogeny of dendritic cells
(DCs) has been the center of controversy.
Seminal studies in the recent years have
now established DCs as a distinct hema-
topoietic lineage of the mononuclear
phagocyte system specialized in the con-
trol of tissue immunity (Merad and Manz,
2009). The successive DC commitment
steps in the bone marrow include com-
mon myeloid progenitors (CMPs) and
macrophage-DC progenitors (MDPs). It
is at the level of the MDP that DCs
separate from the monocyte-macro-
phage lineage. MDPs, which have lost
the potential to give rise to granulocytes,
erythrocytes, and megakaryocytes, sub-
sequently give rise to monocytes and to
the common DC precursor (CDP). CDPs
give rise to classical DC-restricted pre-
cursors called (pre-DCs) and plasmacy-
toid DCs in the bone marrow but have
lost the potential to give rise to mono-
cytes. Pre-DCs leave the bone marrow
and circulate through the blood to home
to lymphoid organs where they differen-
tiate into lymphoid (Merad and Manz,
2009) and nonlymphoid tissue resident
DCs (Helft et al., 2010). Previous data
have also shown that common lymphoid
progenitors can give rise to DCs; how-
ever, the exact contribution of this lineage
to DC homeostasis in secondarylymphoid organs and nonlymphoid
tissues in vivo remains to be determined
(Merad and Manz, 2009).
The cytokine fms-like thyrosine kinase
3 ligand (Flt3L) and its receptor (Flt3)
are key regulators of DC commitment in
hematopoiesis. Flt3 is expressed on
short-term repopulating hematopoietic
stem cells and is progressively extin-
guished on most hematopoietic lineages
with the exception of the DC precursors
(Merad and Manz, 2009). Loss of Flt3
expression in hematopoietic progenitors
correlates with the loss of DC differentia-
tion potential, whereas enforcement of
Flt3 expression on Flt3-negative progeni-
tors rescues their ability to differentiate
into DCs (Onai et al., 2006). The cytokine
Flt3L is ubiquitously secreted by multiple
tissue stroma and endothelial cells and
by activated T cells (Schmid et al., 2010).
Flt3L as a single cytokine is sufficient to
drive the differentiation of mouse and
human hematopoietic bone marrow pro-
genitors into DCs in vitro (Schmid et al.,
2010). Consistently, mice that are defi-
cient in Flt3L have reduced numbers of
pre-DCs and DCs in lymphoid organs
and nonlymphoid tissues (Helft et al.,
2010). Despite the importance of Flt3 in
DC development, there is surprisingly
little known about how Flt3 expression is
controlled in hematopoiesis. In this issue
of Immunity, Carotta et al. (2010) demon-strate that PU.1 directly controls Flt3 gene
expression on hematopoietic progenitors
in a dose-dependent manner.
The role of PU.1 in DC differentiation
has been suggested more than a decade
ago as mice that lacked PU.1 showed
defects in DC development (Merad and
Manz, 2009). Similar results were ob-
tained with knockdown of PU.1 in human
CD34+ fetal liver precursors (Merad and
Manz, 2009). However, the early lethality
of PU.1-deficient mutant mice precluded
investigations on the role of PU.1 in DC
homeostasis during adult life. Thus it
remains unknown whether PU.1 functions
within the DC lineage or whether its role in
DC differentiation is a consequence of its
role in early myelopoiesis. Previous work
by the same group has shown that PU.1
ablation have distinct effects during adult
and fetal hematopoiesis and revealed that
in contrast to PU.1-deficient embryos,
PU.1 elimination in adults leads to
increased granulopoiesis, suggesting that
PU.1 expression restricts GMP differenti-
ation into granulocytes therefore favoring
the differentiation of the monocyte-DC
lineage (Dakic et al., 2007). In addition, en-
forced expression of PU.1 in hematopietic
progenitors suggested a dose-dependent
role of PU.1 in specifying DC and macro-
phage fate (Bakri et al., 2005; Laiosa
et al., 2006). However, the exact role of
endogenous amounts of PU.1 in adult32, May 28, 2010 ª2010 Elsevier Inc. 583
